Matches in Wikidata for { <http://www.wikidata.org/entity/Q92485753> ?p ?o ?g. }
Showing items 1 to 42 of
42
with 100 items per page.
- Q92485753 description "article scientifique publié en 2019" @default.
- Q92485753 description "artículu científicu espublizáu en marzu de 2019" @default.
- Q92485753 description "scientific article published on 16 March 2019" @default.
- Q92485753 description "wetenschappelijk artikel" @default.
- Q92485753 description "наукова стаття, опублікована 16 березня 2019" @default.
- Q92485753 name "Permanent prostate brachytherapy is safe in men with severe baseline lower urinary tract symptoms" @default.
- Q92485753 name "Permanent prostate brachytherapy is safe in men with severe baseline lower urinary tract symptoms" @default.
- Q92485753 type Item @default.
- Q92485753 label "Permanent prostate brachytherapy is safe in men with severe baseline lower urinary tract symptoms" @default.
- Q92485753 label "Permanent prostate brachytherapy is safe in men with severe baseline lower urinary tract symptoms" @default.
- Q92485753 prefLabel "Permanent prostate brachytherapy is safe in men with severe baseline lower urinary tract symptoms" @default.
- Q92485753 prefLabel "Permanent prostate brachytherapy is safe in men with severe baseline lower urinary tract symptoms" @default.
- Q92485753 P1433 Q92485753-03E6C97C-DF28-4A2A-B19B-1DC4BCD04864 @default.
- Q92485753 P1476 Q92485753-0BD77FB2-BDEA-4152-B7D0-A4BC2F252D91 @default.
- Q92485753 P2093 Q92485753-06F6BD18-B09B-4418-853A-219130668F5B @default.
- Q92485753 P2093 Q92485753-542169FE-2A7A-434F-B767-1C8D0FA2018F @default.
- Q92485753 P2093 Q92485753-AF520C0C-55F6-482E-B5E6-35FE76D4A439 @default.
- Q92485753 P2093 Q92485753-C5794366-C2DD-4B7B-BEF7-62AE5C60335A @default.
- Q92485753 P2093 Q92485753-EC4FB05A-13E0-4929-AA5F-0C1FD2C2F3F5 @default.
- Q92485753 P304 Q92485753-916D8454-6641-4294-B1D5-87D46F371772 @default.
- Q92485753 P31 Q92485753-4E1E1637-7372-4DFB-B872-19B4B83728BB @default.
- Q92485753 P356 Q92485753-C3433244-BBB6-4BDB-ADB0-FBA326695421 @default.
- Q92485753 P433 Q92485753-180D6661-22E5-4018-A58E-52666F43D269 @default.
- Q92485753 P478 Q92485753-CD5AEC0B-A703-4A07-B656-A0961A129E75 @default.
- Q92485753 P577 Q92485753-42E1A4D1-0ABE-41D7-B699-660C69D7E6E8 @default.
- Q92485753 P698 Q92485753-ED6EA2DC-9A92-4047-BCF3-03B2F5C29EEE @default.
- Q92485753 P356 J.BRACHY.2019.02.002 @default.
- Q92485753 P698 30890317 @default.
- Q92485753 P1433 Q1823269 @default.
- Q92485753 P1476 "Permanent prostate brachytherapy is safe in men with severe baseline lower urinary tract symptoms" @default.
- Q92485753 P2093 "Jared S Winoker" @default.
- Q92485753 P2093 "Nelson N Stone" @default.
- Q92485753 P2093 "Reza Mehrazin" @default.
- Q92485753 P2093 "Richard G Stock" @default.
- Q92485753 P2093 "Rollin K Say" @default.
- Q92485753 P304 "332-337" @default.
- Q92485753 P31 Q13442814 @default.
- Q92485753 P356 "10.1016/J.BRACHY.2019.02.002" @default.
- Q92485753 P433 "3" @default.
- Q92485753 P478 "18" @default.
- Q92485753 P577 "2019-03-16T00:00:00Z" @default.
- Q92485753 P698 "30890317" @default.